Literature DB >> 30974509

Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.

Adrian M Di Bisceglie1, Wendy C King2, Mauricio Lisker-Melman3, Mandana Khalili4, Steven H Belle2, Jordan J Feld5, Marc G Ghany6, Harry L A Janssen5, Daryl Lau7, William M Lee8, Simon C Ling5, Stewart Cooper9, Philip Rosenthal4, Kathleen B Schwarz10, Richard K Sterling11, Jeffrey H Teckman1, Norah Terrault4.   

Abstract

Hepatitis B e antigen (HBeAg) is an important serological marker of hepatitis B virus (HBV) infection and is associated with higher levels of viraemia, increased risk of infectivity to others and increased risk of hepatocellular carcinoma. We analysed HBeAg status in a large cohort of adults and children enrolled in Cohort Studies of the Hepatitis B Research Network, long-term natural history studies of chronic HBV infection. A cross-sectional analysis examined factors associated with HBeAg positivity, including demographic and virologic data, across the age spectrum. Among 2241 enrolled participants who met criteria for this analysis, 825 (37%) were seropositive for HBeAg. The prevalence of HBeAg was lower in those with older age, ranging from 85% among those up to 10 years of age to only 12% among those older than 50 years. In addition to age, both race and HBV genotype were independently associated with HBeAg positivity. There was a significant interaction between age and race; the prevalence of HBeAg was significantly higher among Asians > 10-30 years old vs Whites or Blacks who were >10 to 30 years old and those infected with HBV genotype C. Conversely, the presence of the basal core promoter and precore variants was associated with significantly lower prevalence of HBeAg, even when adjusted for age, race and genotype. These data will provide a better understanding of factors associated with seropositivity for HBeAg and may lead to better strategies for preventing HBV infection and broader indications for antiviral therapy.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  e antigen; hepatitis B; natural history

Year:  2019        PMID: 30974509      PMCID: PMC6592737          DOI: 10.1111/jvh.13104

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  31 in total

1.  Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

Authors:  M R Brunetto; M M Giarin; F Oliveri; E Chiaberge; M Baldi; A Alfarano; A Serra; G Saracco; G Verme; H Will
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Authors:  Chien-Jen Chen; Hwai-I Yang; Jun Su; Chin-Lan Jen; San-Lin You; Sheng-Nan Lu; Guan-Tarn Huang; Uchenna H Iloeje
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

3.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

4.  Secular trends of HBeAg prevalence among HBsAg-positive delivery mothers in a hepatitis B endemic area.

Authors:  S N Lu; J H Liu; J H Wang; C C Lu
Journal:  J Trop Pediatr       Date:  2000-04       Impact factor: 1.165

5.  Robust hepatitis B virus genotyping by mass spectrometry.

Authors:  L Ganova-Raeva; S Ramachandran; C Honisch; J C Forbi; X Zhai; Y Khudyakov
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

6.  Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion.

Authors:  H L Chan; M Hussain; A S Lok
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

7.  Hepatitis B e antigen and the risk of hepatocellular carcinoma.

Authors:  Hwai-I Yang; Sheng-Nan Lu; Yun-Fan Liaw; San-Lin You; Chien-An Sun; Li-Yu Wang; Chuhsing K Hsiao; Pei-Jer Chen; Ding-Shinn Chen; Chien-Jen Chen
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

8.  Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.

Authors:  Frank Tacke; Christina Gehrke; Tom Luedde; Albert Heim; Michael P Manns; Christian Trautwein
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.

Authors:  Jeffrey B Schwimmer; Winston Dunn; Gregory J Norman; Perrie E Pardee; Michael S Middleton; Nanda Kerkar; Claude B Sirlin
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

10.  Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.

Authors:  Chee-Kin Hui; Nancy Leung; Siu-Tsan Yuen; Hai-Ying Zhang; Kar-Wai Leung; Lei Lu; Stephen K F Cheung; Wai-Man Wong; George K Lau
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

View more
  5 in total

1.  Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.

Authors:  Daniel Traum; Yue J Wang; Kathleen B Schwarz; Jonathan Schug; David Kh Wong; Harry LA Janssen; Norah A Terrault; Mandana Khalili; Abdus S Wahed; Karen F Murray; Phillip Rosenthal; Simon C Ling; Norberto Rodriguez-Baez; Richard K Sterling; Daryl Ty Lau; Timothy M Block; Michael D Feldman; Elizabeth E Furth; William M Lee; David E Kleiner; Anna S Lok; Klaus H Kaestner; Kyong-Mi Chang
Journal:  JCI Insight       Date:  2021-04-08

2.  Molecular epidemiology of hepatitis B virus genotypes and subgenotypes in ethnic minority populations, Yunnan province, China.

Authors:  Zhe Dong; Jiang-Rong Li; Zhi-Xian Zhao; Lin Xu; Wen Yu; Wen-Yu Kang; Qiong-Fen Li
Journal:  Epidemiol Infect       Date:  2021-11-17       Impact factor: 2.451

3.  Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China.

Authors:  Yunqi Liu; Ximei Wang; Fuping Xu; Dengren Li; Huimin Yang; Nan Sun; Yu-Chen Fan; Xiangdong Yang
Journal:  J Clin Transl Hepatol       Date:  2021-07-23

4.  Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes.

Authors:  Daryl T Y Lau; Lilia Ganova-Raeva; Junyao Wang; Douglas Mogul; Raymond T Chung; Mauricio Lisker-Melman; Kyong-Mi Chang; Obaid S Shaikh; Harry L A Janssen; Abdus S Wahed; Anna S Lok
Journal:  Hepatology       Date:  2021-05       Impact factor: 17.298

5.  Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study.

Authors:  William M Lee; Wendy C King; Harry L A Janssen; Marc G Ghany; Robert J Fontana; Michael Fried; Richard K Sterling; Jordan J Feld; Junyao Wang; Douglas B Mogul; Stewart L Cooper; Adrian M Di Bisceglie
Journal:  J Viral Hepat       Date:  2021-08-11       Impact factor: 3.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.